Safety Study of Melatonin in Stroke Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 140 participants.
Also called NCT01863277
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 140 participants
- Sponsor
- Wolfson Medical Center
- Registry
-
NCT01863277
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- Israel
- Registry status
- Unknown status
Technical summary
Registry record NCT01863277. Randomized; triple masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2014-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety Study of Melatonin in Stroke Patients
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Melatonin
- Intervention (Drug)
- placebo
- Lead sponsor
- Wolfson Medical Center
Record details
- Record id
cardio:ct-nct01863277- Content hash
a4d9a0ddc164a3015941e5ccc106c6b6bc4c34645c39f926223e8a4605237aa7